PDE4A and hydrops fetalis: To examine the role of PDE4 in cardiac hypertrophy and HF, we administered PDE4 inhibitor roflumilast (1 mg/kg/day) or vehicle by oral gavage once daily to mice subjected to chronic ISO (7.5 mg/kg/day) intraperitoneal injection for 1 month.